116131-44-3 Usage
Uses
Used in Pharmaceutical Industry:
3-(Bromomethyl)tetrahydro-2H-pyran is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its bromomethyl group allows for the formation of new carbon-carbon bonds, facilitating the creation of complex molecular structures with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(Bromomethyl)tetrahydro-2H-pyran serves as an essential building block for the development of new agrochemicals. Its unique chemical properties enable the synthesis of novel compounds with improved pesticidal or herbicidal activities, contributing to more effective crop protection.
Used in Fragrance and Flavor Industry:
3-(Bromomethyl)tetrahydro-2H-pyran is utilized as a versatile intermediate in the production of fragrances and flavors. Its ability to form new chemical bonds allows for the creation of a wide range of aromatic compounds, enhancing the sensory experience in various consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 116131-44-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,1,3 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 116131-44:
(8*1)+(7*1)+(6*6)+(5*1)+(4*3)+(3*1)+(2*4)+(1*4)=83
83 % 10 = 3
So 116131-44-3 is a valid CAS Registry Number.
116131-44-3Relevant academic research and scientific papers
CYANO-SUBSTITUTED INDOLE COMPOUNDS AND USES THEREOF AS LSD1 INHIBITORS
-
, (2017/09/15)
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders: (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein.
PURINE DERIVATIVES AS IMMUNOMODULATORS
-
, (2008/12/08)
The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants